aid: renibus-therapeutics
name: Rénibus Therapeutics
description: 'Rénibus Therapeutics is a privately held clinical-stage biopharmaceutical
  company headquartered in Southlake, Texas, developing treatments for cardio, renal
  and metabolic disease. Its pipeline is led by veverimer, a non-absorbed polymer in
  Phase 3 for metabolic acidosis in chronic kidney disease, and RBT-1 (stannic protoporfin
  / iron sucrose), a first-in-class intravenous pharmacologic preconditioning agent
  given 24-48 hours before non-emergent cardiac surgery to reduce post-operative complications,
  which holds FDA Breakthrough Therapy and Fast Track designations and completed the
  pivotal Phase 3 PROTECT trial. The company publishes a corporate marketing site,
  a news and events feed, an expanded access policy and patient information, but operates
  no developer program, public API, or machine-readable API contract.'
image: https://www.renibus.com/wp-content/uploads/2022/10/renibus-therapeutics-logo-retina.png
url: https://raw.githubusercontent.com/api-evangelist/renibus-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biopharmaceutical
- Pharmaceuticals
- Life Sciences
- Healthcare
- Clinical Trials
- Nephrology
- Cardiovascular
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.renibus.com/
- type: About
  url: https://www.renibus.com/about-us/
- type: Blog
  url: https://www.renibus.com/news-and-events/
- type: BlogRSS
  url: https://www.renibus.com/feed/
- type: Support
  url: https://www.renibus.com/contact-us/
- type: PrivacyPolicy
  url: https://www.renibus.com/privacy-policy/
- type: TermsOfService
  url: https://www.renibus.com/terms-and-conditions/
- type: Careers
  url: https://www.renibus.com/careers/
- type: DomainSecurity
  url: security/renibus-therapeutics-domain-security.yml
- type: SecondaryMarket
  url: https://forgeglobal.com/renibus-therapeutics_stock/
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Rénibus is a clinical-stage drug developer whose entire public web presence is
    a ten-page WordPress/Avada marketing site (about, approach, patients, news, careers,
    contact, policies) with no developer, docs, or API section; api./developer./docs./portal.renibus.com
    do not resolve in DNS and every contract-discovery path returns 404 — the only machine-readable
    endpoint on the host is the generic WordPress /wp-json/ CMS route, which is not a product API.
  evidence:
  - url: https://www.renibus.com/openapi.json
    status: 404
  - url: https://www.renibus.com/.well-known/agent-card.json
    status: 404
  - url: https://www.renibus.com/.well-known/security.txt
    status: 404
  - url: https://www.renibus.com/llms.txt
    status: 404
  - url: https://www.renibus.com/sitemap.xml
    status: 200
  checked: '2026-08-05'